Skip to main content

Table 2 Clinical and imaging data in two centers

From: A novel radiomics based on multi-parametric magnetic resonance imaging for predicting Ki-67 expression in rectal cancer: a multicenter study

Characteristic

Center 1

(n = 199)

Center 2

(n = 60)

Ki67(H,%)

148 (74.37%)

50 (83.33%)

Age(y)

63.82 ± 11.38

68.45 ± 9.76

Sex(F,%)

75 (37.69%)

21 (35%)

CEA(Positive,%)

94 (47.24%)

23 (38.33%)

NC(Yes,%)

42 (31.66%)

17 (28.3%)

Location(Middle,%)

57 (41.71%)

31 (51.67%)

LD(mm)

42.2 (27.8)

48.3 (33.2)

ID(mm)

14.0 (8.5)

15.55 (5.5)

CIR(%)

75.0 (25.0)

84.83 (33.0)

ADC value(×10−3mm2/s)

0.81 ± 0.17

0.8 ± 0.11

EP(Obvious,%)

106 (53.27%)

32 (53.33%)

mrT stage(T3-4,%)

128 (64.32%)

32 (53.33%)

mrN stage(N0,%)

115 (57.79%)

36 (60%)

rM stage(Positive,%)

16 (8.04%)

6 (10%)

mrCRM(Positive,%)

59 (29.65%)

24 (40%)

  1. Continuous variables (LD, ID, CIR ) are presented as the median and interquartile range (IQR)
  2. ADC apparent diffusion coefficient, CEA carcinoembryonic antigen, CIR circum-involvement ratio, EP Enhancement pattern, ID Infiltration depth, LD Long diameter, mrCRM circumferential resection margin of MR, mrT stage T stage of MR, mrN stage N stage of MR, NC Neoadjuvant chemotherapy, rM assess metastasis by radiological examinations